Introduction
Fructose is a monosaccharide abundant in many fruits, vegetables, honey, high fructose corn syrup, soft drinks and prepackaged foods. It was initially considered a beneficial sweetener for diabetic patients due to its low glycemic index compared to glucose; however, recently, it has been shown that overconsumption of fructose can be pathogenic. Studies have provided strong evidence of its adverse effects on human and animal health [1] . Fructose is predominantly and rapidly metabolized in the liver where it promotes de novo lipogenesis [1] . Fructose consumption has been shown to enhance the risk of metabolic syndrome, including obesity and insulin resistance and type 2 diabetes (T2D) by accelerating de novo lipogenesis and increasing very low-density lipoprotein (VLDL) biogenesis in humans and animal models [1, 2] . Fructose overconsumption has been reported to cause adverse metabolic effects such as increased visceral and intrahepatic fat accumulation, which are known to promote the development of nonalcoholic fatty liver disease (NAFLD), a highly prevalent liver disease that is linked with metabolic disorders such as obesity, T2D, hypertension and cardiometabolic disease [1] . Although ample research, including epidemiological studies, has described the harmful effects of fructose on human and animal health, the underlying molecular processes behind its lipogenic effects are still poorly understood.
MicroRNAs (miRNAs) are small noncoding RNA (~22 nucleotide long) that regulate gene expression and function. They bind to the 3′-UTR or 5′-UTR of target mRNA and either suppress protein translation or promote mRNA degradation [3] . More importantly, it has been shown that a single miRNA has the potential to target multiple mRNAs, and a single mRNA can be targeted by multiple miRNAs, which in turn enables them to regulate several groups of mRNAs within a signaling pathway or network and generate a powerful impact on diverse cellular processes [4] . Thus, understanding how dietary factors such as fructose and fat can alter miRNA expression and characterizing the diet-induced changes in expression of miRNA and their target mRNA is key to understanding the molecular mechanisms underlying the metabolic syndrome.
miRNAs induced by high-fat diet (HFD) have drawn considerable attention because of their critical roles in the pathogenesis of metabolic disorders [5] . However, the impact of high-fructose diet on hepatic miRNA expression profiles and the putative role of these miRNAs in fructose-induced hyperlipidemia and insulin resistance are not fully understood. In this study, we identified a new set of hepatic miRNA whose expression profiles were significantly altered by high fructose diet using small RNA deep sequencing, followed by in-depth bioinformatics analysis. Subsequent target prediction and pathway functional enrichment analysis further identified that the targeted mRNAs of these miRNAs assembled as hubs which regulate multiple key metabolic pathways associated with the onset of diet-induced metabolic disorders. We further compared the miRNA profiles induced by HFD with those induced by high-fructose diet and discovered that their miRNA expression profiles were different with certain miRNAs that were upregulated by fructose but downregulated by HFD or vice versa. This may suggest that fructose and HFD induced metabolic disorders via different pathogenic pathways. In summary, our study provides novel mechanistic insights into the fructose-induced hyperlipidemia and insulin resistance by identifying a novel miRNA network and their interaction with the key genes in lipid and carbohydrate metabolic signaling.
Materials and methods

Animal protocols
All animal experiments were approved by the University of Nebraska-Lincoln Institutional Animal Care and Use Committee and were carried out under the institutional guidelines for ethical animal use. Male mice (C57BL/6J) at 12 weeks of age were purchased from Jackson Laboratory (Bar Harbor, ME, USA). MiR-378a-depleted mice (miR-378-KO) and their wild-type (WT) littermates are a kind gift from Dr. Vincent Giguere (McGill University, Montreal, Canada). Animals were housed on alternating 12-h light and dark cycles with free access to food and water. After a week of acclimatization, two groups of mice (n=6/per group) were fed either chow (Envigo, Madison, WI, USA; ID: 2016) or a high-fructose diet (60% fructose, ID: 161.506; Dyets, Bethlehem, PA, USA) for 4 weeks. Dietary compositions are provided in Table 1 . Food intake and body weight were monitored every 3 days. Intraperitoneal (ip) glucose tolerance tests were performed weekly. Briefly, mice were fasted for 12 h and then received glucose (2 g/kg, ip) and blood glucose was measured via tail vein bleeding using a handheld glucometer (Contour/Next; Bayer). At the end of the feeding trial, mice were fasted for 12 h and anesthetized using isoflurane and livers were excised, frozen in liquid nitrogen and stored at −80 °C for further analysis.
Cell culture, transfection and treatments
The rat hepatoma cell line McA-RH7777 (McA) was obtained from America Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), 4.5 g/L glucose and 0.5% penicillin/streptomycin. Cells were grown in T75 flasks at 37 °C, 5% CO 2 , with the media changed every other day and cells passaged every 3-4 days. For transfection, the cells were seeded onto 6-well plates (0.3×106) and maintained in DMEM-containing 4.5 g/L glucose. When the cells reached 60%-70% confluence, cells were transfected with 1.0 μg of plasmid cDNA encompassed either a GFP reading frame or miR-125b-5p (Vigene Biosciences, Rockville, MD, USA) by Lipofectamine 2000. Twenty-four hours after transfection, the cells were treated with palmitate (PA; 100 μM) in DMEM (4.5 g/L) without FBS for additional 24 h. Total RNAs were collected at the end points of each treatment as described below.
miRNA extraction and miRNA sequencing profiling
Total RNA, including miRNA, was isolated from the chow-and fructosefed mouse livers using miRNeasy Mini Kit (Qiagen) following the manufacturer's instructions. The miRNA profiling was conducted using Illimina HiSeq 2500 sequencer by Genomics and Microarray Core in UT Southwestern Medical Center (Dallas, TX, USA). Libraries were prepared using Illumina TruSeq Small RNA Sample preparation kit (Illumina, USA). Six replicates were sequenced for each treatment.
RNA isolation, reverse transcription and qRT-PCR
Total RNA was isolated from tissue using TRIzol (Life Technologies, Grand Island, NY, USA). RNA integrity was confirmed using a NanoDrop 2000 (Wilmington, DE, USA). First-strand cDNA was synthesized with oligo (dT) and random primers using a High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Life Technologies). Quantification of gene expression was performed on Applied Biosystems real-time-PCR system StepOnePlus. Relative induction of gene mRNA expression was calculated using the expression of 18s for normalization. Sequences of forward and reverse primers (5′ to 3′) used in this study are shown in Supplementary Table 1.
MiRNA sequencing data analysis
For bioinformatics analysis, the CAP-miSeq was applied to identify mouse miRNAs and calculate their expression [6] . The miRBase (Version 21) was used as reference library ( http://www.mirbase.org ). We have carefully filtered out the low-quality reads and strictly mapped the qualified reads to all known mature sequences, precursor sequences and the mouse genome. The differentially expressed miRNAs between fructose-and chow-fed mice were analyzed using the R package, edgeR and only those miRNAs with P value<.05 were considered significantly differential [7] . Hierarchical clustering ( http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm ) was performed and a heat map was generated to show the differential gene patterns where green represented downregulation while red represented upregulation compared to the chow-fed controls.
Target prediction and functional analysis
As the functions of miRNA can be inferred based on its gene target, we extracted the known miRNA gene targets from miRTarBase [8] , DIANA-Tarbase and also predicted new targets using MiRanda ( http://www.microrna. org ) and TargetScan ( http://www.targetscan.org ). The gene interaction network was generated through Cytoscape [9] .
Statistical analyses
Statistical analysis of qRT-PCR data was done with GraphPad Prism 6 (La Jolla, CA, USA) using Student's t test. All results are presented as means ± S.E.M. Asterisks (*) indicate statistically significant differences of P<.05 compared to controls.
Results
High-fructose feeding induces insulin resistance which is accompanied with aberrant expression of miRNAs in mouse livers
To establish an insulin-resistant animal model, two groups of C57BL/6J mice (n=6/group) were fed either chow or a high-fructose diet (60% caloric from fructose). Caloric intake was monitored daily and was found to be comparable between chow-and fructose-fed mice (Supplementary Figure 1A ). Body weights were comparable between chowand fructose-fed mice during the first 2 weeks of feeding, but were significantly increased in the fructose-fed mice from week 3 (Supplementary Figure 1B ). At week 4 of high-fructose feeding, plasma triglycerides and cholesterol were significantly higher in the fructose-fed mice compared to the chow-fed mice (Supplementary Figure 1C) , indicating the development of hyperlipidemia. Glucose tolerance tests further showed that plasma glucose levels in the fructose-fed mice were significantly higher at 30, 60, 90 and 120 min compared to the chowfed mice after glucose injection (Supplementary Figure 1D) , suggesting the development of glucose intolerance in these mice. To investigate the impact of high-fructose feeding on hepatic miRNA expression, miRNAs were extracted from livers and subjected to miRNA expression profiling by illumine-based deep sequencing. 303 mature miRNAs were detected through small noncoding RNA sequencing analysis. Among them, expression profiles of 45 miRNAs were found to be significantly different (P <.05) between fructose feeding and chow diet. Of these 45 miRNAs, 19 were upregulated and 26 were downregulated with fructose feeding. A heat map was constructed to visualize the changes of these miRNAs ( Figure 1A ). Relative expression of these miRNAs in the livers of chow-and fructose-fed mice is presented in Figure 1B . These results indicate that aberrant expression of miRNA profiles may be associated with the development of hyperlipidemia and insulin resistance in the fructose-fed mice. (Figure 2 ; Tables 2A and 2B ). The following miRNAs were downregulated: miR-223-3p, miR-33-5p, miR-145a-3p, miR-125b-5p and miR-128-3p, and the following miRNAs were upregulated: miR-19b-3p, miR-101a-3p-3p, miR-30a-5p, miR-378a-3p and miR-582-3p (Tables  2A and 2B ). Computing prediction further revealed that the potential target genes of these miRNAs included IRS-1 and FOXO-1 that mediate insulin signaling, SREBP-1c, SREBP-2, ChREBP, and Insig-2 (insig2a and -2b) that are associated with hepatic de novo lipid synthesis as well as MTTP and apoB that are involved in VLDL assembly and secretion [10] [11] [12] [13] . A schematic elucidating the network of interactions between these miRNAs, their potential target genes and the pathways involved is presented in Figure 2 (solid lines represent connections between miRNAs and potential target genes and broken lines represent associations between miRNAs and metabolic pathways). This network indicated that one miRNA can be involved in multiple pathways, whereas one gene can be a common target of several miRNAs that were induced by fructose feeding. For example, miR-223-3p potentially regulates mRNA expression of IRS-1 and apoB, and may be involved in pathways associated with insulin resistance and NAFLD (Table 2A) . However, at the same time, IRS-1 is also a common target of miR-33-5p, miR-128-3p, miR-145a-3p, miR101a-3p, miR-125b-5p and miR-30-5p (Tables 2A and 2B ). Detailed association between the aberrantly expressed miRNAs induced by high-fructose feeding, their potential target genes and the pathways are described in Tables 2A  and 2B . This intriguing finding further stresses the unique and complex regulatory nature of miRNAs on cellular activity. It is now well accepted that an individual miRNA has the ability to regulate several groups of genes within a signaling pathway, whereas multiple miRNAs can assemble as a network to collectively target a key gene in a signaling pathway [4] . This action significantly amplifies the regulatory effects of miRNAs in diverse cellular and physiological activities [4] .
The association between fructose-induced miRNAs and their putative target genes
To determine whether expression of the potential target genes was altered with fructose feeding, we measured the mRNA levels of IRS-1, FOXO1, SREBP-1c/2, ChREBP (Mlxipl), Insig-1, Insig-2, MTTP and apoB in the livers of chow-and fructose-fed mice by qRT-PCR. Expression of IRS-1 and Insig-2 (Insig-2a and Insig-2b) mRNAs was significantly reduced, whereas mRNAs of FOXO1, SREBP-1c, SREBP-2, ChREBP, MTTP and apoB were significantly increased in the fructose-fed mice compared to chow-fed mice ( Figure 3A-D) . The expression profiles of these mRNAs inversely correlated with the abundances of their predicted miRNAs, suggesting that aberrant expressions of these miRNAs may, at least partially, contribute to the abnormal mRNA expression of these genes ( Figures 1A and 3A-D) . For instance, downregulation of miR-223-3p, miR-33-5p, miR-145a-3p, miR-125b-5p and miR-128-3p by fructose feeding may account for the increased mRNA abundance of FOXO1, ChREBP, MTTP and apoB due to the decreased interaction between these miRNAs and their target mRNAs (Figure 3A -D; Table 2A ). On the other hand, upregulation of miR-101a-3p, miR-30a-5p and miR-378a-3p seems to target mRNAs of IRS-1 and Insig-2 which resulted in decreased mRNA expression of these two genes (Figure 3A -D; Table 2B ). Expression of the miR-378 family, including miR-378a, b, c and d, and miR-125a/b, was either significantly upregulated or downregulated upon fructose feeding ( Figure 1A and B). To specifically determine the relationship between miRNAs and their potential target genes, we manipulated the expression of miR-378a and miR-125b-5p via genetic intervention or in vitro overexpression. We overexpressed a plasmid vector encompassed miR-125b-5p in McA cell and determined mRNA expression of MTTP and apoB by qRT-PCR. As shown in Figure 3E , mRNA abundance of MTTP was significantly reduced in the miR-125b-5p overexpressing cells compared to mock transfected cells ( Figure 3E ). Presence of miR-125b-5p further prevented free fatty acid, palmitic acid (PA), induced overexpression of apoB mRNA ( Figure 3F ). Next, we subjected the WT and genetic depletion of miR-378a mice (miR-378a-KO) to the high-fructose diet and found that depletion of miR-378a protected the mice from fructose-induced reduction of PI3K and IRS-1 ( Figure 3G ). Interestingly, we found that the abundance of miR-19b-3p and miR-582-3p was not inversely associated with their target mRNAs. Upregulation of these two miRNAs was found to be associated with increased mRNA levels of their target genes, such as Table 2B ). At a glance, this is at odds with the widely accepted view of miRNA function to downregulate their target genes. However, recent studies have found that in addition to targeting mRNA degradation, miRNAs can also upregulate mRNA expression. The mRNA expression could be activated by the direct action of micro-ribonucleoproteins (miRNPs) and/ or indirectly relieved from miRNA-mediated repression by abrogating the action of repressive miRNPs [14] . Taken together, our study identifies a set of metabolic genes which are common targets of the miRNAs induced by fructose feeding. Our data further implies that an individual miRNA has the potential to either downregulate or upregulate its targeted mRNAs simultaneously, whereas an individual mRNA can be targeted by multiple miRNAs. This finding is in agreement with the recently identified mechanisms of action of miRNAs.
Identification of novel physiological function for the fructose induced miRNAs
In an attempt to identify additional novel functions of the 10 miRNAs that are altered by fructose feeding, we conducted intensive literature research for the reported physiological activities of these miRNAs. We found that miR-33-5p, also known as miR-33, is a well-characterized miRNA that is profoundly involved in hepatic triglyceride and cholesterol metabolism through targeting SREBP-1c gene expression [19] . In the current study, we found that expression of miR-33 was inversely associated with the mRNA abundance of ChREBP ( Figures 1A  and 3B ), a major transcription factor involved in de novo lipogenesis in response to high-carbohydrate diet [1] . This may suggest that miR-33 could also regulate ChREBP in fructose metabolism. The reduced miR-33 in the fructose-fed mice may be responsible, at least partially, for the activation of ChREBP and the subsequent hyperlipidemia induced by high-fructose feeding. Identification of ChREBP as a potential target of miR-33 broadens the targeting profile of miR-33 and may provide rationale for using this miRNA to treat carbohydrate-induced hyperlipidemia. Moreover, we found that miR-101a-3p, miR-30a-5p and miR-582-3p have been reported to be involved in various cellular activities other than energy metabolic signaling. For example, expression of miR-101 is associated with skeletal muscle cell proliferation and differentiation [15] and can protect cardiac fibroblasts against hypoxiainduced apoptosis [16] . Cellular abundances of miR-30a-5p and miR-582-3p are implicated in the development of breast cancer [17] and bladder cancer [18] . Thus, the current study would be the first to report that these three miRNAs are also involved in regulating lipid and carbohydrate metabolism. Our study further identified that miR-145a-3p, whose biological relevance has not been defined yet, may play a role in fructose-induced metabolic disorders because its expression profile was significantly downregulated by fructose ( Figure 1A and B) . Taken together, our study revealed that in addition to their roles in cancer development and cell proliferation, miR-101a-3p, miR-30a-5p, miR-582-3p and miRNA-145a-3p are involved in lipid and carbohydrate metabolism and may contribute to the onset of metabolic syndrome induced by high-fructose feeding.
High-fructose diet and HFD induce different miRNA expression profiles in the livers
To explore whether the fructose-induced miRNA profile differs from that by HFD, we searched for published miRNA data sets that may have similar experimental design as ours but used high-fat feeding instead of high fructose. Conducting vigorous literature research in the GEO database (http://www.ncbi.nlm.nih.gov/geo/ ) and PubMed, we found very little literature on this topic. We then used the miRNAs listed in Figure 1A as a starting point and searched for the expression patterns of each individual miRNA under high-fat feeding condition for comparison. Due to the limited reports on high fat-induced miRNA profiles, we were unable to collect a complete profile match from HFD. Expression patterns of the miRNAs with high-fructose feeding diet (from current study) and HFD (from literature reports) are presented in Table 3 . Interestingly, we noticed that the expression patterns of miRNAs induced by fructose differed from those induced by HFD (Table 3) . MiR-99b-5p, miR-150-5p, miR-100-5p, miR-223-3p and miR-128-3p that were downregulated by fructose were upregulated in the livers of high fat-fed rats or mice (Table 3 ) [5, 20] . In contrast, miR-130a, miR-30a-5p, miR-203-3p, miR-574-5p and miR-20a-5p that were induced by highfructose feeding were reduced in the high fat-fed rats or mice (Table  3 ) [5, 21, 22] . This intriguing finding suggests that different molecular mechanisms are involved in the development of metabolic syndrome induced by these two lipogenic diets.
Discussion
Fructose-induced miRNAs in hepatic insulin signaling
In this study, we found that IRS-1 was inhibited by fructose feeding which could be a consequence of the increased expression of miR-30a-5p, miR-101a-3p, miR-378a-3p and/or the decreased expression of miR-145-3p, miR-33, miR-223-3p, miR-125b-5p and miR-128-3p as all of these miRNA content seed sequences to potentially interact with the 3′-UTR of IRS-1 mRNAs. IRS-1 mediates insulin signaling by relaying the signal from the insulin receptor to downstream signaling molecules that regulate glucose and lipid metabolism [13] . Regulation of IRS1 by miR-128a has been reported previously to be involved in myoblast proliferation and myotube hypertrophy in skeletal muscle [26] . Determination of miR-128-3p, along with other miRNAs stated above, in regulating expression of IRS-1mRNAin the livers of fructosefed mice provides novel mechanistic insight into the fructose-induced metabolic disorders. The observation that IRS-1 could be a common target of multiple miRNAs further strengthens the concept that multiple miRNAs can assemble as a regulatory network to repeatedly target an individual mRNA and generate synergistic impact on the expression of the target gene [4] . In this study, we observed that the mRNA abundance of FOXO1 was elevated in the livers of fructose-fed mice. FOXO1 belongs to the family of forkhead transcription factors involved in several cellular processes, including cell division, DNA repair, apoptosis, insulin signaling and lipid metabolism [27] . This observation is in accordance with a previous study which showed that protein levels of FOXO1 were increased by high-fructose feeding in hamsters [28] . Bioinformatics prediction further revealed that FOXO1 could be a potential common target of miR-19b-3p, miR-145-3p, miR-128-3p and miR-582-3p. It is very likely that the decreased levels of miR-145 and/or miR-128 caused by fructose feeding ease their inhibitory effects on FOXO1 mRNA expression, thus increasing FOXO1 expression and contributing to the onset of diet-induced hyperglycemia. Regulation of FOXO1 by miRNAs highlights the complexity and fine balance between diverse cellular signaling in maintaining metabolic homeostasis.
Fructose-induced miRNAs in hepatic lipid and lipoprotein metabolism
The development of hyperlipidemia is closely associated with the development of T2D [1] . Hepatic de novo lipid synthesis is controlled by SREBPs, which induce expression of genes involved in fatty acid, triglyceride and cholesterol synthesis [11] . Activation of SREBPs is regulated by three ER membrane-bound proteins -Insig-1, Insig-2, and SCAP protein [29] . Low cellular sterol triggers the dissociation of the SCAP-SREBP complex from Insig-1 and Insig-2, thus allowing SCAP-SREBP complex to move to the Golgi apparatus, where the SREBPs are activated by proteolytic cleavage [29] . Hyperlipidemia is one of the major pathological phenotypes observed in high fructose-induced insulin-resistant rodent models. However, the underlying mechanisms are not fully understood. Our study suggests that reduced expression of Insig-2 may derepress the inhibitory effect of Insig-2 on the precursors of SREBPs and enhance activation of SREBP-1c and -2, which may result in hyperactivation of SREBPs, leading to the activation of hepatic de novo lipogenesis. The increased lipid substrates along with elevated levels of apoB and MTTP might favor the assembly and secretion of VLDL from hepatocytes and contribute to the hyperlipidemia induced by fructose.
In summary, our study identified a novel set of miRNAs that are abnormally expressed in the livers of fructose-fed mice. These miRNAs assemble as a regulatory network that cooperatively targets lipid metabolic pathways and insulin signaling at multiple levels to amplify its regulatory effect on the target genes and contribute to pathogenesis of fructose-induced insulin resistance. The miRNA profile induced by high-fructose feeding differs from that of HFD, which implicates the different metabolic mechanisms in high fructose-and high fat-induced metabolic disorders. This study provides novel insight into the molecular mechanism of pathogenesis of high-fructose diet-induced metabolic syndrome and may provide rationale for pharmaceutical design to manipulate the expression of miRNAs in the prevention and treatment of high carbohydrate-induced metabolic syndrome. Conflict of interest -The authors declare that they have no conflicts of interest with the contents of this article.
